User profiles for Benjamin Seeliger

Benjamin Seeliger

Medical Doctor, Hannover Medical School
Verified email at mh-hannover.de
Cited by 1589

[HTML][HTML] Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19

…, C Feuerborn, P Maier, S Schulz, B Al, B Seeliger… - Nature, 2022 - nature.com
Anorexia and fasting are host adaptations to acute infection, and induce a metabolic switch
towards ketogenesis and the production of ketone bodies, including β-hydroxybutyrate (BHB) …

Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study

…, D Firinu, R Padoan, A Egan, B Seeliger… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …

Circulating cardiovascular microRNAs in critically ill COVID‐19 patients

A Garg, B Seeliger, AA Derda, K Xiao… - European journal of …, 2021 - Wiley Online Library
Aims Coronavirus disease 2019 (COVID‐19) is a still growing pandemic, causing many
deaths and socio‐economic damage. Elevated expression of the severe acute respiratory …

Between inflammation and thrombosis: endothelial cells in COVID-19

…, G Gorkiewicz, M Zacharias, B Seeliger… - European …, 2021 - Eur Respiratory Soc
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current
coronavirus disease (COVID-19) pandemic [1]. Over recent months, a plethora of novel research …

[HTML][HTML] Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

…, I Olivotto, C Salvarani, B Seeliger… - Nature reviews …, 2023 - nature.com
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …

[HTML][HTML] Injury to the endothelial glycocalyx in critically ill patients with COVID-19

K Stahl, PA Gronski, Y Kiyan, B Seeliger… - American journal of …, 2020 - atsjournals.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the so-called
coronavirus disease (COVID-19), which is characterized by a broad spectrum of clinical …

[HTML][HTML] Anti-IL-5 therapy in patients with severe eosinophilic asthma–clinical efficacy and possible criteria for treatment response

N Drick, B Seeliger, T Welte, J Fuge… - BMC pulmonary medicine, 2018 - Springer
Background Interleukin-5 (IL-5) antibodies represent a promising therapeutic option for patients
with severe eosinophilic asthma. To date, no official treatment response criteria exist. In …

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?

B Seeliger, J Sznajd, JC Robson, A Judge… - …, 2017 - academic.oup.com
Objectives. Advances in diagnostic techniques have led to better distinction between types of
vasculitis, potentially affecting the utility of the 1990 ACR classification criteria for vasculitis. …

[HTML][HTML] Neuro-Sjögren: peripheral neuropathy with limb weakness in Sjögren's syndrome

T Seeliger, NK Prenzler, S Gingele, B Seeliger… - Frontiers in …, 2019 - frontiersin.org
Objective: Sjögren's syndrome is a heterogeneous inflammatory disorder frequently involving
peripheral nerves with a wide spectrum of sensory modalities and distribution patterns. …

[HTML][HTML] The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling

…, PD Lee, MM Hoeper, T Welte, B Seeliger… - …, 2022 - thelancet.com
Background COVID-19 is characterized by a heterogeneous clinical presentation, ranging
from mild symptoms to severe courses of disease. 9–20% of hospitalized patients with severe …